ABOUT COMPANY
Artelo Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. The company is headquartered in La Jolla, California.
|
EARNINGS
Gross Profit (TTM): 0
Market Capitalization: 21954200
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 0
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.398
Dividend Date: 2019-06-21
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -2945807
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|